LODDO, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 155.241
NA - Nord America 13.475
AS - Asia 5.206
SA - Sud America 750
AF - Africa 124
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 174.809
Nazione #
IT - Italia 152.285
US - Stati Uniti d'America 13.318
CN - Cina 1.862
SG - Singapore 1.821
UA - Ucraina 897
SE - Svezia 634
BR - Brasile 604
VN - Vietnam 418
DE - Germania 340
FI - Finlandia 298
GB - Regno Unito 279
FR - Francia 266
IN - India 258
HK - Hong Kong 193
KR - Corea 127
BD - Bangladesh 92
CA - Canada 88
IQ - Iraq 66
TR - Turchia 54
JP - Giappone 46
PK - Pakistan 45
MA - Marocco 43
AR - Argentina 39
NL - Olanda 39
RU - Federazione Russa 36
BE - Belgio 35
MX - Messico 31
EC - Ecuador 30
JO - Giordania 30
AT - Austria 28
ID - Indonesia 28
SA - Arabia Saudita 23
ES - Italia 22
VE - Venezuela 21
UZ - Uzbekistan 20
IR - Iran 19
PL - Polonia 19
ZA - Sudafrica 19
PH - Filippine 17
EG - Egitto 16
TW - Taiwan 15
JM - Giamaica 13
CL - Cile 12
CO - Colombia 12
LT - Lituania 11
PY - Paraguay 11
TN - Tunisia 10
MY - Malesia 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
UY - Uruguay 8
AU - Australia 7
IL - Israele 7
PE - Perù 7
AZ - Azerbaigian 6
KZ - Kazakistan 6
NG - Nigeria 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
IE - Irlanda 5
KE - Kenya 5
LV - Lettonia 5
OM - Oman 5
PA - Panama 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
ET - Etiopia 4
GE - Georgia 4
MU - Mauritius 4
SK - Slovacchia (Repubblica Slovacca) 4
CH - Svizzera 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RO - Romania 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EU - Europa 2
GT - Guatemala 2
GY - Guiana 2
LB - Libano 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
AM - Armenia 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
Totale 174.789
Città #
Cagliari 148.247
Uta 3.585
Fairfield 1.466
Woodbridge 1.216
Ashburn 1.196
Singapore 972
Houston 947
Chandler 883
Ann Arbor 645
San Jose 582
Dallas 568
Seattle 564
Wilmington 552
Jacksonville 513
Boardman 504
Cambridge 500
Nyköping 402
Beijing 344
Dearborn 302
Los Angeles 198
Nanjing 162
Hong Kong 158
Helsinki 156
Hefei 148
Lauterbourg 148
Ho Chi Minh City 140
Santa Clara 140
Shanghai 131
Boston 127
Buffalo 104
Seoul 102
New York 98
Council Bluffs 87
The Dalles 75
Hanoi 73
San Diego 58
Shenyang 55
São Paulo 53
Pune 51
Guangzhou 45
Jiaxing 41
Tianjin 41
Frankfurt am Main 40
Milan 40
Nanchang 40
Hebei 39
Munich 37
Redwood City 37
Sassari 37
Toronto 37
Tokyo 35
Dong Ket 34
Casablanca 33
Columbus 33
Atlanta 32
Changsha 32
Mountain View 32
Brussels 31
Chicago 25
Orem 25
London 24
Verona 24
Jinan 23
Washington 23
Amman 22
Kunming 22
Nuremberg 20
Rio de Janeiro 20
Zhengzhou 20
Orange 19
Phoenix 19
Stockholm 19
Brooklyn 18
Da Nang 18
Norwalk 18
Tashkent 18
Warsaw 18
Redondo Beach 17
Amsterdam 16
Manchester 16
San Francisco 16
Bengaluru 15
Chennai 15
Haiphong 15
Wuhan 15
Fuzhou 14
Ankara 13
Baghdad 13
Denver 13
Düsseldorf 13
Guayaquil 13
Auburn Hills 12
Hangzhou 12
Jakarta 12
Ningbo 12
Palermo 12
Porto Alegre 12
Queven 12
Vienna 12
Belo Horizonte 11
Totale 167.654
Nome #
Synthesis, structural characterization and biological evaluation of 4'-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides 3.669
Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives 3.428
Synthesis and antiviral activity of new phenylimidazopyridines and N-benzylidenequinolinamines derived by molecular simplification of phenylimidazo[4,5-g]quinolines 3.003
Activity of bis(7-hydroxycoumarin) Mannich bases against bovine viral diarrhoea virus 2.917
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 2.883
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents 2.674
N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)anilines: A novel class of anti-RSV agents 2.655
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents 2.650
Quinoxaline derivatives as new inhibitors of coxsackievirus B5 2.619
Dichloro-phenyl-benzotriazoles: a new selective class of human respiratory syncytial virus entry inhibitors 2.613
Benzimidazole derivatives endowed with potent antileishmanial activity 2.463
A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems 2.428
Synthesis and biological evaluation of (acyl)hydrazones and thiosemicarbazones obtained via in situ condensation of iminium salts with nitrogen-containing nucleophiles. 2.421
Synthesis of novel fluoro analogues of MKC442 as microbicides 2.418
Synthesis and anti-HIV-1 evaluation of some novel MC-1220 analogs as non-nucleoside reverse transcriptase inhibitors 2.418
Antiviral activities of 5-chlorobenzotriazole derivatives 2.183
1,2-benzisothiazol-3(2h)-one benzenesulfonamides targeting the hiv nucleocapsid proteins are potential microbicide candidates for the prevention of mucosal hiv transmission/acquisition 2.178
A Computationally-Based Explanation for the Knocking Out Activity of the Microbicide MC1220 2.106
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles 2.100
Facile synthesis of the NNRTI microbicide MC-1220 and synthesis of its phosphoramidate prodrugs 2.097
Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques 2.045
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors 2.041
Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives 2.037
Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation. 2.000
Design, synthesis, antiviral evaluation, and SAR studies of new 1-(phenylsulfonyl)-1H-pyrazol -4-yl-methylaniline derivatives. 1.917
Synthesis and antiviral evaluation of 1-[(2-Phenoxyethyl)oxymethyl] and 6-(3,5-Dimethoxybenzyl) analogues of HIV drugs emivirine and TNK-651 1.900
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 1.897
Synthesis and biological evaluation of new 3-phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones 1.872
9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp) 1.799
Synergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase 1.756
Synthesis and evaluation of in vitro biological activity of 4-substituted arylpiperazine derivatives of 1,7,8,9-tetrachloro-10,10-dimethoxy-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione 1.752
Preliminary anti-Coxsackie activity of novel 1-[4-(5,6-dimethyl(H)-1H(2H)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 1.747
Styrylbenzimidazoles. Synthesis and biological activity - part 3 1.743
null 1.667
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus 1.638
Further SAR studies on bicyclic basic merbarone analogues as potent antiproliferative agents 1.613
null 1.577
Results on different formulations of an NNRTI candidate (MC 1220) for application as topical microbicide 1.553
Antimicrobial activity of 10-(diphenylmethylene)-4-azatricyclo[5.2.1.0 2,6]dec-8-ene-3,5-dione derivatives 1.503
In vitro evaluation of the anti-HIV-1 activity of Liposomes and gel ingredients 1.489
2,3-dihydro-1,2-diphenyl-substituted 4H-pyridinone derivatives as new anti flaviviridae inhibitors 1.470
1,2-benzisothiazol-3(2H)-one benzenesulfonamides as new microbicide candidates for prevention of mucosal HIV infections 1.390
Synthesis and anti-HIV-1 activity of new fluoro-HEPT analogues: an investigation on fluoro versus hydroxy substituents 1.331
Syntheses and in vitro biologic screening 3 of 1-aryl-10H-[1,2,4]triazolo[30,40:3,4][1,2,4]triazino[5,6-b]indoles 1.267
In vitro evaluation of the anti-HIV-1 activity of liposomes and gel ingredients 1.263
Aryl nucleoside H-phosphonates. Part 15: Synthesis, properties and, anti-HIV activity of aryl nucleoside 50-a-hydroxyphosphonates 1.256
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives 1.227
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines. 1.213
A novel synthetic route for the anti-HIV drug MC-1220 and its analogues 1.183
Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus Macaques with RT-SHIV 1.150
null 1.150
Anti-BVDV activity evaluation of naphthoimidazole derivatives compared with parental imidazoquinoline compounds. 1.143
Platinum and palladium-triazole complexes as highly potential antitumor agents 1.124
Antiviral activity of benzotriazole based derivatives 1.108
Synthesis and in vitro anti-HIV activity of N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives using MTT method 1.108
null 1.096
Synthesis, in vitro antiproliferative and anti-HIV activity of new derivatives of 2-Piperazino-1,3-benzo[d]thiazoles 1.072
null 1.044
null 1.022
Inhibition of enterovirus a71 by a novel 2-phenyl-benzimidazole derivative 1.021
Potent flaviviridae inhibitors: targeted finger domain of RdRp. 1.019
Potent flaviviridae inhibitors: targeted finger domain of RdRp 1.011
null 1.009
In vitro evaluation of the anti-viral activity of Aryl and Heteroaryl-Azoenammines 995
null 994
null 950
Mystery unveiled: benzimidazole docks different domains in Flaviviridae 946
Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV) 944
Data from a phase IIb clinical trial evaluating valopicitabine (NM283) combined with pegylated interferon in treatment-naïve hepatitis C patients 929
null 896
null 895
null 868
null 857
null 840
Synthesis, Antitumor and Antiviral In Vitro Activities of New Benzotriazole-Dicarboxamide Derivatives 837
Mystery Unveiled: Benzimidazole docks in different domains of HCV and BVDV RdRp 836
null 833
null 832
null 786
null 760
Hepatitis C: New therapeutic approaches 757
(Hetero)aroyl esters of 2-(N-phthalimido)ethanol and analogues: parallel synthesis, anti-HIV-1 activity and cytotoxicity 741
Hindered nucleoside analogs as inhibitors of HCV RNA-dependent RNA polymerase: evolving vistas 737
null 737
null 732
null 717
null 712
Biological evaluation of 10-(diphenylmethylene)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione derivatives 696
null 694
Benzimidazoles as potent non nucleosidic inhibitors of Respiratory Syncytial Virus 652
Benzimidazole-2-Phenyl-Carboxamides as Dual-Target Inhibitors of BVDV Entry and Replication 638
Synthesis and antiproliferative acticity of basic thioanalogues of merbarone 628
Synthesis and in vitro antiproliferative activity of new benzothiazole derivatives 606
null 595
Erratum to: Syntheses and in vitro biological screening of 1-aryl-10 H-[1,2,4]triazolo[3′,4′:3,4][1,2,4]triazino[5,6-b]indoles 589
null 581
Synthesis and in vitro antiviral studies of bis(pivaloyloxymethyl)ester derivative of 9-[((phosphonomethyl)aziridin-1-yl)methyl]adenine(PMAMA) and analogues 578
Synthesis and in vitro antiproliferative activity of new adamantylthiazolyl-1,3,4-oxadiazoles 567
Design, synthesis, and antiviral activities of new benzotriazole-based derivatives 540
2-Arylbenzimidazoles as antiviral and antiproliferative agents-Part 1 527
Totale 142.168
Categoria #
all - tutte 235.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 235.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021769 0 0 0 0 0 0 0 0 0 0 0 769
2021/20229.286 1.122 754 429 653 814 756 501 459 1.008 822 971 997
2022/202313.159 1.260 1.425 1.335 995 1.155 1.352 723 857 981 1.015 1.377 684
2023/202417.171 624 965 938 1.330 1.794 2.593 2.665 1.248 762 1.046 1.645 1.561
2024/202528.017 6.778 7.458 3.279 2.949 1.577 1.734 2.647 213 378 271 326 407
2025/202610.162 576 453 1.172 821 777 798 1.707 1.111 792 1.034 645 276
Totale 175.328